RE:RE:RE:TODAY’S NUMBERSVery true Rev, a low volume environment is absolutely needed to pull off something like this. Spectral just needs to keep on enrolling and then the volume will come as we get even closer to 150. As of last update, we just need 7 more placebo/SOC patients and 14 more PMX patients. We've gotten to a point where the mortality results of the final patients will have a very limited effect on the overall numbers. Cheers to that Finish Line being in sight!